(Q43524729)

24 November 2017

title

Therapeutic targets in radiotherapy (English)

1 reference

adaptive radiation therapy

24 November 2017

main subject

0 references

author name string

Brown JM

series ordinal

1

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

International Journal of Radiation Oncology Biology Physics

24 November 2017

published in

1 reference

24 November 2017

volume

49

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

319-326

1 reference

The role of the H-ras oncogene in radiation resistance and metastasis

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Increased radioresistance of EJras-transformed human osteosarcoma cells and its modulation by lovastatin, an inhibitor of p21ras isoprenylation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Studies on the Influence of the Presence of an ActivatedRasOncogene on thein VitroRadiosensitivity of Human Mammary Epithelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Non-Ras targets of farnesyltransferase inhibitors: focus on Rho.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Prognostic value of epidermal growth factor receptor expression in cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced ce

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Measurement of Human Tumour Oxygenation Status by a Polarographic Needle Electrode: An analysis of inter- and intratumour heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Oxygenation predicts radiation response and survival in patients with cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Hypoxia-Specific Cytotoxins in Cancer Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

AQ4N: an alkylaminoanthraquinone N-oxide showing bioreductive potential and positive interaction with radiation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901482-6

7 January 2021

10.1016/S0360-3016(00)01482-6

Identifiers

DOI

1 reference

24 November 2017

1 reference